| Literature DB >> 34325985 |
Christopher D Morrison1, Marina A DuVall2, Cristal M Hill1, Redin A Spann1, David H McDougal3.
Abstract
Hypoglycemia is a major barrier to clinical management of persons with diabetes. Emerging evidence supports a role for leptin in gating hypoglycemic counterregulation. This work demonstrates that male leptin receptor null, Zucker (fa/fa), rats display severe impairments in hypoglycemic counterregulation. Thus, augmenting leptin levels may have clinical utility for preventing hypoglycemia.Entities:
Keywords: Diabetes; Hypoglycemia; Leptin; Leptin receptors; Zucker rats
Mesh:
Substances:
Year: 2021 PMID: 34325985 PMCID: PMC8435018 DOI: 10.1016/j.jdiacomp.2021.107994
Source DB: PubMed Journal: J Diabetes Complications ISSN: 1056-8727 Impact factor: 3.219